Aztech Sciences Competitors and Similar CompaniesClear all
Aztech Sciences's competitors and similar companies include CanSino Biologics, IRBM and FibroGen.
 Aztech Sciences Aztech Sciences is a biotechnology company providing contract research and development services. |  CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | ||
Founding Date | Founding Date 2017 | Founding Date 2009 | Founding Date 1990 | Founding Date 1993 |
Type | Type Private | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations Hauppauge, US HQ | Locations Tianjin, CN HQ | Locations Rome, IT HQ | Locations San Francisco, US HQ |
Employees | Employees 1 | Employees 1,10526% decrease | Employees 2931% decrease | Employees 53115% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) €30.4m (Y, 2022) | Revenue (est.) $6.4m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥81.4m (FY, 2025) | Cost of goods N/A | Cost of goods $556k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥1.1b (FY, 2025) | Gross profit N/A | Gross profit $5.9m (FY, 2025) |
Net income | Net income N/A | Net income ¥27.9m (FY, 2025) | Net income N/A | Net income $183.5m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View company
IRBM
HQ
Rome, IT
Employees
293↓ 1% decrease
IRBM is a company that provides drug discovery and preclinical development services.
View companyFibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View company